Stock market melts down over Trump’s tariffs, and biotech's pain keeps growing

As President Donald Trump’s tariffs roil financial markets, biopharma is no exception. The XBI, an index fund viewed as the biotech’s market barometer, was down 3% in early trading Monday after closing 9% lower on ...